Basic Information
| LncRNA/CircRNA Name | RP5-1120P11.3 |
| Synonyms | NA |
| Region | GRCh38_6:44073913-44077952 |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | hepatocellular carcinoma |
| ICD-0-3 | C22.0 |
| Methods | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown |
| Sample | The human HCC cell lines HepG2, Smmc-7721 and Huh7, HCC clinical samples and para-carcinoma tissues |
| Expression Pattern | up-regulated |
| Function Description | we identified a novel long non-coding RNA, RP5-1120P11.3 that ectopically expressed in HCC. Further characterization of RP5-1120P11.3 revealed that RP5-1120P11.3 promoted proliferation and invasion of HCC while inhibited apoptosis. Importantly, our data revealed that miR-196b-5p interacted with and was regulated by RP5-1120P11.3 via a sponging mechanism. Inhibition of miR-196b-5p attenuated the phenotypes resulted from RP5-1120P11.3 inhibition. Moreover, our data showed that miR-196b-5p inhibited the expression of WIPF2 in HCC and thus illustrated a regulatory axis of RP5-1120P11.3/miR-196b-5p/WIPF2 that facilitated the progression of HCC. In addition, our data showed that RP5-1120P11.3 contributed to the xenograft generation in vivo via regulating miR-196b-5p and WIPF2. |
| Pubmed ID | 31299165 |
| Year | 2019 |
| Title | RP5-1120P11.3 promotes hepatocellular carcinoma development via hsa-miR-196b-5p/WIPF2 axis |
External Links
| Links for RP5-1120P11.3 | GenBank HGNC NONCODE |
| Links for hepatocellular carcinoma | OMIM COSMIC |